The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RAS alterations: Next-generation sequencing of 1,526 patients with diverse malignancies reveals prognostic and therapeutic correlates.
 
Shumei Kato
No Relationships to Disclose
 
Ryosuke Okamura
No Relationships to Disclose
 
Gregory A. Daniels
Consulting or Advisory Role - Merck
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Nektar (Inst); Viralytics (Inst)
 
Aaron Goodman
Consulting or Advisory Role - Gerson Lehrman Group; Mitsubishi Tanabe Pharma
 
Suzanna Lee
No Relationships to Disclose
 
Noor Khalid
No Relationships to Disclose
 
Rachel Collier
No Relationships to Disclose
 
Manvita Mareboina
No Relationships to Disclose
 
Paul Riviere
No Relationships to Disclose
 
Theresa J Whitchurch
No Relationships to Disclose
 
Paul T. Fanta
No Relationships to Disclose
 
Jason K. Sicklick
Consulting or Advisory Role - bioTheranostics; Grand Rounds; Loxo
Research Funding - Blueprint Medicines; Foundation Medicine; Novartis
 
Razelle Kurzrock
Leadership - CureMatch
Stock and Other Ownership Interests - CureMatch
Consulting or Advisory Role - Actuate Therapeutics; Loxo; Sequenom
Speakers' Bureau - Roche
Research Funding - Foundation Medicine (Inst); Genentech (Inst); Guardant Health (Inst); Incyte (Inst); Merck Serono (Inst); Pfizer (Inst); Sequenom (Inst)